FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to compositions containing PKC delta activator and/or PKC-alpha inhibitor, and a pharmaceutically acceptable carrier with the above composition containing no Ca2+ and Mg2+ cations, wherein the pharmaceutically acceptable carrier is an aqueous carrier containing KCl 0.2 g/l, anhydrous KH2PO4 0.2 g/l, NaCl 8 g/l and anhydrous Na2HPO4 1.15 g/l.
EFFECT: group of inventions refers to compositions and methods for accelerating the process of wound healing and/or inflammation relief on a skin wound area.
95 cl, 55 dwg, 1 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2008 |
|
RU2404799C2 |
| METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2004 |
|
RU2392959C1 |
| METHODS OF REGULATING INFLAMMATION MEDIATORS AND PEPTIDES USED IN THEM | 2007 |
|
RU2429004C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| HYDROPHOBIC MODIFIED preS-DERIVED PEPTIDES OF HEPATITIS B VIRUS (HBV) AND USE THEREOF AS HBV AND HDV ENTRY INHIBITORS | 2009 |
|
RU2492182C2 |
| PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2690377C2 |
| SELECTIVE INHIBITORY PEPTIDES Nox-1 AND USE THEREOF | 2014 |
|
RU2699726C2 |
| METHODS OF DEPRESSING INFLAMMATION MEDIATOR RELEASE AND PEPTIDES APPLIED FOR THIS PURPOSE | 2007 |
|
RU2423376C2 |
| AGONISTS OF RECEPTOR (VPAC2) OF HYPOPHYSIAL PEPTIDE, ACTIVATING ADENYLATCYCLASE (PACAP), AND PHARMACOLOGICAL METHODS OF THEIR APPLICATION | 2003 |
|
RU2360922C2 |
| NEW DERIVATIVES OF OXYNTOMODULIN AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY | 2012 |
|
RU2612906C2 |
